medroxyprogesterone has been researched along with Neoplasms in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 38 (82.61) | 18.7374 |
1990's | 1 (2.17) | 18.2507 |
2000's | 4 (8.70) | 29.6817 |
2010's | 3 (6.52) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, GL; Aragaki, AK; Chlebowski, RT; Espeland, MA; Howard, BV; Jackson, RD; Johnson, KC; LaCroix, AZ; Lewis, CE; Manson, JE; Margolis, KL; Martin, LW; Prentice, RL; Rossouw, JE; Shumaker, SA; Stefanick, ML; Thomson, CA; Wactawski-Wende, J | 1 |
Contu, P; Dessì, M; Macciò, A; Madeddu, C; Mantovani, G; Massa, E; Panzone, F; Serpe, R | 1 |
Mantovani, G | 1 |
BLOOM, HJ; DUKES, CE; MITCHLEY, BC | 1 |
BAKER, WH; BLOOM, HJ; DUKES, CE; MITCHLEY, BC | 1 |
ARPELS, C; BABCOCK, VI; SOUTHAM, CM | 1 |
CRAIG, JM; KISTNER, RW; STEINER, GJ | 1 |
ANDERSON, DG | 1 |
PELNER, L; RHOADES, MG | 1 |
Astara, G; Deiana, L; Gramignano, G; Lusso, MR; Macciò, A; Madeddu, C; Mantovani, G; Massa, E; Serpe, R | 1 |
Amato, G; Capuano, F; Carella, C; Figlia, A; Papaleo, C; Zito, GA | 1 |
Pawlicki, M; Zuchowska-Vogelgesang, B | 1 |
Battaglia, A; Bernardo, G; Brunner, K; Cavalli, F; Ganzina, F; Goldhirsch, A; Isetta, AM; Robustelli della Cuna, G; Sacchetti, G; Tamassia, V | 1 |
Camaggi, CM; Canova, N; Giovannini, M; Murari, G; Pannuti, F; Strocchi, E | 1 |
Angelelli, B; Camaggi, CM; Costanti, B; Ferrari, P; Giovannini, M; Pannuti, F; Strocchi, E; Zebini, E | 1 |
Angelelli, B; Camaggi, CM; Colalongo, F; Costanti, B; Giambiasi, ME; Lelli, G; Pannuti, F; Strocchi, E | 1 |
DeStefano, F; Guidotti, R; Jones, V; Layde, PM; Levenson, AG; Michelson, M; Ory, HW; Peterson, H; Rubin, GL; Wingo, P | 1 |
Ordelman, GJ | 1 |
Priestman, TJ | 1 |
Revaz, C | 1 |
Angelelli, B; Lelli, G; Mondini, F; Monetti, N; Pannuti, F; Piana, E; Strocchi, E; Zanichelli, L | 1 |
Oldenkamp, EP; van Laar, PH; van Os, JL; Verschoor, JS | 1 |
Minkin, S | 1 |
Fraser, IS; Weisberg, E | 1 |
Benagiano, G; Fraser, I | 1 |
Blomster, M | 1 |
Camaggi, CM; Costanti, B; Di Marco, AR; Giovannini, M; Pannuti, F; Strocchi, E | 1 |
Dragosky, M; Gustavo Gercovich, F; Martínez, RE; Morgenfeld, E; Murro, H; Presman, A; Sorrentino, M | 1 |
Barnes, DM; Hayden, DW; Johnson, KH; Johnston, SD; Kiang, DT | 1 |
Furberg, C; Grady, D; Herrington, D; Hulley, S; Hunninghake, D; Khan, S; Vittinghoff, E; Wenger, NK | 1 |
Bachmann, P; Béal, J; Benamouzig, R; Blanc-Vincent, MP; Colomb, V; Desport, JC; Gory-Delabaere, G; Kere, D; Melchior, JC; Nitenberg, G; Raynard, B; Scheiner, S; Senesse, P | 1 |
Coleman, ME; Feenstra, ES; Frank, DW; Gilbertson, TJ; Kimball, FA; Kirton, KT; Murchison, TE; Quinlan, WJ | 1 |
Mohberg, NR; Schwallie, PC | 1 |
Geyer, G; Lang, I; Spona, J; Templ, H; Zielinski, CC | 1 |
Keller, PJ | 1 |
Camaggi, CM; Pannuti, F; Strocchi, E | 1 |
Beghelli, P; Camaggi, CM; Costanti, B; Ferrari, P; Pannuti, F; Strocchi, E | 1 |
Lusk, W; Sadoff, L | 1 |
Gaudin, D; Guthrie, L; Yielding, KL | 1 |
Cali, RW | 1 |
Mann, CJ | 1 |
5 review(s) available for medroxyprogesterone and Neoplasms
Article | Year |
---|---|
[New antineoplastic agents, their value and use].
Topics: Aminacrine; Antineoplastic Agents; Aspartic Acid; Cisplatin; Etoposide; Humans; Ifosfamide; Interferons; Medroxyprogesterone; Medroxyprogesterone Acetate; Methyltestosterone; Neoplasms; Phosphonoacetic Acid; Razoxane; Tamoxifen; Teniposide; Vinca Alkaloids | 1982 |
A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate.
Topics: Australia; Blood Pressure; Breast Neoplasms; Contraceptives, Oral; Drug Implants; Female; Fertility; Fetus; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; Thrombophlebitis; Uterine Cervical Neoplasms | 1981 |
The Depo-Provera debate. Commentary on the article "Depo-Provera, a critical analysis".
Topics: Animals; Breast Feeding; Carbohydrate Metabolism; Carcinogens; Delayed-Action Preparations; Dogs; Endometrium; Family Planning Services; Female; Haplorhini; Humans; Immunosuppression Therapy; Infant, Newborn; Liver; Liver Function Tests; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Neoplasms; Pregnancy; Risk; United States; United States Food and Drug Administration | 1981 |
[Hormonal contraception using depot preparations].
Topics: Abnormalities, Drug-Induced; Blood Coagulation; Carbohydrate Metabolism; Cardiovascular Diseases; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Levonorgestrel; Liver; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Pregnancy; Risk | 1986 |
Depot-medroxyprogesterone acetate (DMPA) and cancer: memorandum from a WHO meeting.
Topics: Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Risk | 1986 |
6 trial(s) available for medroxyprogesterone and Neoplasms
Article | Year |
---|---|
Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.
Topics: Aged; Cardiovascular Diseases; Cause of Death; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone; Middle Aged; Mortality; Neoplasms; Postmenopause; Risk | 2017 |
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia.
Topics: Appetite Stimulants; Cachexia; Carnitine; Eicosapentaenoic Acid; Female; Humans; Interleukin-6; Male; Medroxyprogesterone; Megestrol Acetate; Middle Aged; Neoplasms; Thalidomide; Vitamin B Complex | 2010 |
Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia.
Topics: Aged; Body Composition; Cachexia; Carnitine; Contraceptives, Oral, Hormonal; Eicosapentaenoic Acid; Endpoint Determination; Energy Metabolism; Female; Humans; Male; Medroxyprogesterone; Megestrol; Middle Aged; Motor Activity; Neoplasms; Prognosis; Thalidomide | 2010 |
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress.
Topics: Adult; Aged; Anorexia; Ascorbic Acid; Cachexia; Carbocysteine; Celecoxib; Dietary Supplements; Docosahexaenoic Acids; Female; Humans; Linear Models; Male; Medroxyprogesterone; Middle Aged; Neoplasms; Nutritional Support; Oxidative Stress; Pyrazoles; Statistics, Nonparametric; Sulfonamides; Thioctic Acid; Treatment Outcome; Vitamin A; Vitamin E | 2006 |
Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.
Topics: Aged; Coronary Disease; Double-Blind Method; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Fractures, Bone; Hospitalization; Humans; Leg Injuries; Medroxyprogesterone; Multivariate Analysis; Neoplasms; Proportional Hazards Models; Pulmonary Embolism; Risk Factors; Surgical Procedures, Operative; Venous Thrombosis | 2000 |
Protective effect of high-dose medroxyprogesterone acetate (HD-MPA) on hematological toxicity induced by chemotherapy for advanced solid tumors: a multicentric controlled clinical trial. MPA-Hematology Italian Cooperative Group.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Tests; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Female; Humans; Leukopenia; Lung Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Random Allocation; Rectal Neoplasms; Thrombocytopenia; Time Factors | 1986 |
35 other study(ies) available for medroxyprogesterone and Neoplasms
Article | Year |
---|---|
HORMONE-DEPENDENT TUMOURS OF THE KIDNEY. I. THE OESTROGEN-INDUCED RENAL TUMOUR OF THE SYRIAN HAMSTER. HORMONE TREATMENT AND POSSIBLE RELATIONSHIP TO CARCINOMA OF THE KIDNEY IN MAN.
Topics: Adenocarcinoma; Animals; Carcinoma; Cortisone; Cricetinae; Diethylstilbestrol; Estrogens; Kidney Neoplasms; Medroxyprogesterone; Mesocricetus; Neoplasms; Neoplasms, Experimental; Pathology; Physiology; Research; Testosterone; Toxicology | 1963 |
HORMONE-DEPENDENT TUMOURS OF THE KIDNEY. II. EFFECT OF ENDOCRINE ABLATION PROCEDURES ON THE TRANSPLANTED OESTROGEN-INDUCED RENAL TUMOUR OF THE SYRIAN HAMSTER.
Topics: Adrenalectomy; Animals; Castration; Cricetinae; Diethylstilbestrol; Estradiol; Estrogens; Humans; Kidney; Kidney Neoplasms; Male; Medroxyprogesterone; Mesocricetus; Neoplasms; Neoplasms, Experimental; Orchiectomy; Pharmacology; Research; Testis; Testosterone; Toxicology | 1963 |
EFFECT OF STEROIDS ON HUMAN CELL CULTURES; SUSTAINING EFFECT OF HYDROCORTISONE.
Topics: 17-Ketosteroids; Androsterone; Dehydroepiandrosterone; Estradiol; Etiocholanolone; Hydrocortisone; Hydroxyprogesterones; Medroxyprogesterone; Neoplasms; Pharmacology; Progestins; Research; Steroids; Testosterone; Tissue Culture Techniques | 1964 |
HISTOLOGICAL EFFECTS OF PROGESTINS ON HYPERPLASIA AND CARCINOMA IN SITU OF THE ENDOMETRIUM--FURTHER OBSERVATIONS.
Topics: Carcinoma in Situ; Drug Therapy; Endometrial Hyperplasia; Endometrium; Female; Geriatrics; Humans; Hydroxyprogesterones; Hyperplasia; Hysterectomy; Medroxyprogesterone; Menopause; Mestranol; Neoplasms; Norethindrone; Norethynodrel; Pathology; Progestins; Uterine Neoplasms | 1963 |
MANAGEMENT OF ADVANCED ENDOMETRIAL ADENOCARCINOMA WITH MEDROXYPROGESTERONE ACETATE.
Topics: Adenocarcinoma; Disease Management; Female; Geriatrics; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Palliative Care; Uterine Neoplasms | 1965 |
HOST-TUMOR ANTAGONISM. 34. THE USE OF PROGESTATIONAL AGENTS TO RETARD HOMOGRAFT REJECTION IN RABBITS; A PILOT STUDY.
Topics: Allografts; Animals; Female; Hydroxyprogesterones; Immune Tolerance; Immunosuppressive Agents; Medroxyprogesterone; Neoplasms; Pharmacology; Pilot Projects; Pregnancy; Pregnancy, Animal; Progestins; Rabbits; Research; Skin Transplantation; Transplantation Immunology; Transplantation, Homologous | 1965 |
ACTH and cortisol plasma levels in cancer patients treated with medroxyprogesterone acetate at high dosages.
Topics: Adrenocorticotropic Hormone; Adult; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Hydrocortisone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Uterine Neoplasms | 1984 |
Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology.
Topics: Biological Availability; Breast Neoplasms; Female; Humans; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Time Factors | 1982 |
Medroxyprogesterone acetate (MAP) plasma levels after simultaneous oral and intramuscular administration in cancer patients.
Topics: Administration, Oral; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms | 1982 |
Medroxyprogesterone acetate (MAP) plasma levels after multiple high-dose administration in advanced cancer patients.
Topics: Administration, Oral; Antineoplastic Agents; Biological Availability; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms | 1983 |
The anabolic effect of high dose medroxyprogesterone acetate in oncology.
Topics: Anabolic Agents; Anorexia; Hemodynamics; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Nitrogen; Pain; Psychomotor Performance | 1983 |
Mortality among young black women using contraceptives.
Topics: Adolescent; Adult; Black or African American; Contraception; Contraceptives, Oral; Family Planning Services; Female; Georgia; Humans; Intrauterine Devices; Medroxyprogesterone; Medroxyprogesterone Acetate; Mortality; Neoplasms; Parity; Risk; Vaginal Creams, Foams, and Jellies | 1984 |
[The occurrence of mammary tumors in bitches following treatment with Delvosteron injection or Perlutex injection for the prevention of estrus, compared to 2 control groups].
Topics: Animals; Dog Diseases; Dogs; Female; Mammary Glands, Animal; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Progesterone; Progesterone Congeners | 1984 |
Quality of life after cytotoxic chemotherapy: discussion paper.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Quality of Life; Self-Assessment; Surveys and Questionnaires | 1984 |
[Real and false risks of injectable hormonal contraception].
Topics: Abnormalities, Drug-Induced; Amenorrhea; Contraceptive Agents, Female; Female; Humans; Infant, Newborn; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Pregnancy; Risk | 1984 |
The effect of high dose medroxyprogesterone acetate on water and salt metabolism in advanced cancer patients.
Topics: Antineoplastic Agents; Body Water; Electrolytes; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Water-Electrolyte Balance | 1984 |
Oestrus control and the incidence of mammary nodules in bitches, a clinical study with two progestogens.
Topics: Animals; Contraception; Dog Diseases; Dogs; Female; Mammary Glands, Animal; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Progesterone; Progesterone Congeners | 1981 |
Depo-Provera: a critical analysis.
Topics: Abnormalities, Drug-Induced; Animals; Breast Feeding; Contraceptive Agents, Female; Dogs; Female; Haplorhini; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Neoplasms; Pregnancy; United States; United States Food and Drug Administration; Uterine Neoplasms | 1980 |
Injectable hormonal contraceptives: technical and safety aspects.
Topics: Adolescent; Adult; Animals; Contraceptive Agents, Female; Dogs; Drug Labeling; Family Planning Services; Female; Fertility; Haplorhini; Humans; Injections, Intramuscular; Medroxyprogesterone; Menstruation Disturbances; Neoplasms; Norethindrone; Rats | 1982 |
[Monica was reported when she refused to give Depo-Provera. Interview by Susanne Gäre].
Topics: Contraceptives, Oral; Contraceptives, Oral, Synthetic; Humans; In Vitro Techniques; Medroxyprogesterone; Neoplasms | 1982 |
Medroxyprogesterone acetate (MAP) relative bioavailability after single high-dose administration in cancer patients.
Topics: Administration, Oral; Biological Availability; Chromatography, Gas; Dose-Response Relationship, Drug; Humans; Injections, Intramuscular; Medroxyprogesterone; Neoplasms | 1982 |
[Myelopoietic effect of medroxyprogesterone acetate at high parenteral doses in the cancer patient].
Topics: Antineoplastic Agents; Bone Marrow; Female; Hematopoiesis; Humans; Male; Medroxyprogesterone; Middle Aged; Neoplasms; Random Allocation | 1982 |
Feline mammary hypertrophy/fibroadenoma complex: clinical and hormonal aspects.
Topics: Adenofibroma; Animals; Castration; Cat Diseases; Cats; Female; Hydrocortisone; Hypertrophy; Hysterectomy; Male; Mammary Glands, Animal; Medroxyprogesterone; Megestrol; Neoplasms; Neoplasms, Hormone-Dependent; Pregnancy; Progesterone; Promegestone; Receptors, Progesterone | 1981 |
[Standards, Options and Recommendations (SOR) for the use of appetite stimulants in oncology. Work group. Federation of the French Cancer Centres (FNCLCC)].
Topics: Adrenal Cortex Hormones; Appetite Stimulants; Cachexia; Humans; Medroxyprogesterone; Megestrol; Neoplasms; Progesterone Congeners; Review Literature as Topic | 2000 |
Medroxyprogesterone and palliative care: new indication. No impact on quality of life.
Topics: Antineoplastic Agents, Hormonal; Appetite; Appetite Stimulants; Clinical Trials as Topic; Humans; Medroxyprogesterone; Neoplasms; Palliative Care; Quality of Life; Treatment Outcome; Weight Loss | 2001 |
Mammary tumors and serum hormones in the bitch treated with medroxyprogesterone acetate or progesterone for four years.
Topics: Adenoma; Animals; Dogs; Dose-Response Relationship, Drug; Estradiol; Female; Growth Hormone; Hormones; Hydrocortisone; Hyperplasia; Insulin; Mammary Glands, Animal; Medroxyprogesterone; Neoplasms; Progesterone; Prolactin; Thyrotropin; Time Factors; Triiodothyronine | 1979 |
Medroxyprogesterone acetate: an injectable contraceptive.
Topics: Animals; Female; Humans; Medroxyprogesterone; Menstruation; Neoplasms; Uterine Hemorrhage | 1977 |
Medroxyprogesterone acetate lowers plasma corticotropin and cortisol but does not suppress anterior pituitary responsiveness to human corticotropin releasing factor.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; beta-Endorphin; Corticotropin-Releasing Hormone; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Pituitary Gland, Anterior; Pituitary-Adrenal System | 1990 |
The role of pharmacokinetics in the clinical treatment of metastases.
Topics: Antineoplastic Agents; Doxorubicin; Epirubicin; Humans; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasms; Tamoxifen | 1988 |
Medroxyprogesterone acetate bioavailability after high-dose intraperitoneal administration in advanced cancer.
Topics: Antineoplastic Agents; Biological Availability; Humans; Injections, Intraperitoneal; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms | 1985 |
The effect of large doses of medroxyprogesterone acetate (MPA) on urinary estrogen levels and serum levels of cortisol T4 LH and testosterone in patients with advanced cancer.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Breast Neoplasms; Dose-Response Relationship, Drug; Estrogens; Female; Humans; Hydrocortisone; Injections, Intramuscular; Kidney Neoplasms; Luteinizing Hormone; Male; Medroxyprogesterone; Melanoma; Middle Aged; Neoplasms; Pituitary-Adrenal System; Testosterone; Thyroid Gland; Thyroxine | 1974 |
Topical and systemic contraceptive agents.
Topics: Blood Pressure; Carbohydrate Metabolism; Contraception; Contraceptive Agents; Contraceptive Devices; Contraceptives, Oral; Contraceptives, Postcoital; Diethylstilbestrol; Female; Humans; Intrauterine Devices; Lipid Metabolism; Male; Medroxyprogesterone; Neoplasms; Pregnancy; Prostaglandins; Thromboembolism | 1974 |
DNA repair inhibition: a new mechanism of action of steroids with possible implications for tumor therapy.
Topics: Contraceptives, Oral; Diethylstilbestrol; Dihydrotestosterone; DNA; DNA Repair; Estradiol; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Lymphocytes; Medroxyprogesterone; Neoplasms; Norethindrone; Norethynodrel; Progesterone; Testosterone; Thymidine; Tritium | 1974 |
Management of the climacteric and postmenopausal woman.
Topics: Aged; Anxiety; Climacteric; Coronary Disease; Depression; Estrogens; Female; Humans; Medroxyprogesterone; Menopause; Middle Aged; Neoplasms; Osteoporosis; Ovary; Psychophysiologic Disorders; Vaginitis; Vasomotor System | 1972 |
Some clinical aspects of problems associated with oestrus and with its control in the bitch.
Topics: Animals; Castration; Dog Diseases; Dogs; Estrus; Female; Mammary Glands, Animal; Medroxyprogesterone; Megestrol; Neoplasms; Pregnancy; Pseudopregnancy; Uterine Diseases | 1971 |